Recently, single-cell transcriptomics was also successfully used for examining the effectiveness of prednisolone in eliminating relapse-initiating clones and identifying patients with need for intensified treatment in MLL-rearranged infant ALL [124]. Here, KMT2A is linked to acute lymphoblastic leukemia.